Attitudes to pharmaceutical promotion techniques among healthcare professionals in the Republic of Tatarstan, Russia

International Journal of Risk and Safety in Medicine

Volumn 20, Issue 1-2, 2008, Pages 57-71

  Burashnikova, Irene S ^a   Ziganshin, Airat U ^b   Ziganshina, Lilia E ^a  

^a KAZAN STATE MEDICAL ACADEMY   (Russian Federation)

^b KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Drug promotion; Health professionals; Pharmaceutical promotion; Pharmaceutical representatives; Republic of Tatarstan; Survey

Indexed keywords

ARTICLE; CONTROLLED STUDY; DRUG INDUSTRY; DRUG MARKETING; GIFT GIVING; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; HUMAN EXPERIMENT; INTERVENTION STUDY; MEDICAL ETHICS; MEDICAL PRACTICE; NORMAL HUMAN; PRESCRIPTION; RUSSIAN FEDERATION; STRUCTURED QUESTIONNAIRE;

EID: 42149133188     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: 10.3233/JRS-2008-0425     Document Type: Article

References (23)

1. J. Avorn, M. Chen and R. Hartley, Scientific versus commercial sources of influence on the prescribing behavior of physicians, Am. J. Med. 73 (1982), 4-8.
2. T.S. Caudill, M.S. Johnson, E.C. Rich and W.P.P.P. McKinney, Physicians, pharmaceutical sales representatives, and the cost of prescribing, Arch. Fam. Med. 5 (1996), 201-206.
3. M.M. Chren and C.S. Laundefeld, Physicians behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary, JAMA 271 (1994), 684-689.
4. S. Fuldal and S. Semin, The influences of drug companies' advertising programs on physicians, Int. J. Health Serv. 30 (2000), 585-595.
5. R.V. Gibbons, F.J. Laundry, D.L. Blouch et al., A comparison of physicians and patients attitudes toward pharmaceutical industry gifts, J. Gen. Intern. Med. 13 (1998), 151-154.
6. R. Moynihan, Who pays for the pizza? Redefining the relationships between doctors and drug companies, BMJ 326 (2003), 1189-1192.
7. R.C. Noble, Physicians and the pharmaceutical industry: an alliance with un-healthy aspects, Perspect. Biol. Med. 36 (1993), 376-394.
8. Obraschenie lekarstvennych sredstv, http://www.regmed.ru.com.
9. S. Okie, What ails the FDA?, N. Engl. J. Med. 352 (2005), 1063-1066.
10. J.P. Orlowski and L. Wateska, The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as free lunch, Chest 102 (1992), 270-273.
11. D.L. Sackett, W.S. Richardson, W. Rosenberg and R.B. Haynes, Evidence-Based Medicine: How to Practice and Teach EBM, Churchill Livingstone, 1997, pp. 227-234.
12. J.P. Shapiro and S. Schultz, Prescriptions: How your doctor makes the choice, US News & World Report 130 (2001), 58-61.
13. B. Sibbald, Doctors asked to take pledge to shun drug company freebies, CMAJ 164 (2001), 531.
14. M.A. Steinman, M.G. Shlipak and S.J. McPhee, Of principles and pens: attitudes and practices of medicine house-stuff toward pharmaceutical industry promotion, Am. J. Med. 110 (2001), 551-557.
15. D. Stryer and O.A. Bero, Characteristics of materials distributed by drug companies: an evaluation of appropriateness, J. Gen. Intern. Med. 11 (1996), 575-583.
16. R.M. Tenery, Jr., Interactions between physicians and health care technology industry, JAMA 283 (2000), 391-393.
17. D.R. Waud, Pharmaceutical promotions - A free lunch?, N. Engl. J. Med. 327 (1992), 351-353.
18. A. Wazana, Physicians and the pharmaceutical industry. Is a gift ever just a gift?, JAMA 283 (2000), 373-380.
19. J. Wechsler, Rough road ahead, Pharm. Execut. 25 (2005), 36-38.
20. S.M. Wolfe, Why do American drug companies spend more than $12 billion a year pushing drugs? Is it education or promotion?, J. Gen. Intern. Med. 11 (1996), 637-639.
21. R.F. Woolard, Addressing the pharmaceutical industry,s influence on professional behaviour (Editorial), CMAJ 107 (1993), 1-4.
22. M.G. Ziegler, P. Lew and B.C. Singer, The accuracy of drug information from pharmaceutical representatives, JAMA 273 (1995), 1296-1298.
23. 15 years of monitoring and one simple conclusion; don't expect sales representatives to help improve healthcare quality, Rev. Prescrire 272 (2006), 383-389.